Active	Status	Sponsor type	Region	Phase	Filter
5 Active 16 Inactive 21 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hollander, Eric
NCT05711940: Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With TRD	Recruiting	3	568	Europe, Canada, US	Psilocybin, COMP360	COMPASS Pathways	Treatment Resistant Depression	03/25	05/25
NCT03197662: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome	Recruiting	2	50	US	Intranasal Oxytocin (IN-OXT), Syntocinon, Matched Placebo	Montefiore Medical Center	Prader-Willi Syndrome, Hyperphagia	08/23	08/23
NCT03848481: CBDV vs Placebo in Children and Adults up to Age 30 With Prader-Willi Syndrome (PWS)	Active, not recruiting	2	14	US	CBDV Compound, Placebo	Montefiore Medical Center, Foundation for Prader-Willi Research, Jazz Pharmaceuticals	Prader-Willi Syndrome	08/24	10/24
NCT03202303: Cannabidivarin (CBDV) vs. Placebo in Children With Autism Spectrum Disorder (ASD)	Recruiting	2	100	US	Cannabidivarin, CBDV, Matched Placebo, Placebo	Montefiore Medical Center, United States Department of Defense, Jazz Pharmaceuticals	Autism Spectrum Disorder	07/24	07/24
NCT05166707: An ERP-based Mobile Intervention as an Adjunctive Treatment for OCD	Recruiting	N/A	30	US	BIXINK OC Free	BIXINK Therapeutics Co., Ltd.	Obsessive-compulsive Disorders and Symptoms, Obsessive-Compulsive Disorder	11/22	05/23